INFLIXIMAB MARKET SHARE AND ASSOCIATED COST SAVINGS FOLLOWING BIOSIMILAR MARKET ENTRY

被引:0
|
作者
Paglinco, Samantha
Abdel-Rasoul, Mahmoud
Mcnicol, Megan
Boyle, Brendan
Dotson, Jennifer
Michel, Hilary
Maltz, Ross
机构
关键词
D O I
10.1093/ibd/izae020.104
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
izae020.10
引用
收藏
页码:S51 / S51
页数:1
相关论文
共 50 条
  • [1] UPTAKE OF BIOSIMILAR INFLIXIMAB: BUDGET SAVINGS OR MARKET EXPANSION ACROSS COUNTRIES?
    Kim, Y.
    Kwon, H. Y.
    Godman, B.
    Moorkens, E.
    Simoens, S.
    Bae, S.
    VALUE IN HEALTH, 2019, 22 : S425 - S425
  • [2] Changes Associated With the Entry of a Biosimilar in the Insulin Glargine Market
    Levy, Joseph
    Chowdhury, Zahra M.
    Socal, Mariana P.
    Trujillo, Antonio J.
    JAMA INTERNAL MEDICINE, 2021, 181 (10) : 1405 - +
  • [3] ANALYSIS OF FACTORS INFLUENCING ORIGINATOR MARKET SHARE FOLLOWING BIOSIMILAR COMPETITION
    Krieger, D.
    Mueller, C.
    Kanjolia, M.
    Dittelman, Z.
    VALUE IN HEALTH, 2023, 26 (06) : S116 - S117
  • [4] Effect of biosimilar market entry on cost of biologics in the United States: The case of filgrastim
    Mouslim, Morgane
    Alexander, Caleb
    Segal, Jodi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 24 - 24
  • [5] Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?
    Kim, Yujeong
    Kwon, Hye-Young
    Godman, Brian
    Moorkens, Evelien
    Simoens, Steven
    Bae, SeungJin
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [6] The Impact of Order and Mode of Market Entry on Profitability and Market Share
    Yigang Pan
    Shaomin Li
    David K. Tse
    Journal of International Business Studies, 1999, 30 : 81 - 103
  • [7] The impact of order and mode of market entry on profitability and market share
    Pan, YG
    Li, SM
    Tse, DK
    JOURNAL OF INTERNATIONAL BUSINESS STUDIES, 1999, 30 (01) : 81 - 103
  • [9] Market share in a post-entry game
    Lee, CB
    Fletcher, LR
    Binner, JM
    Murphy, WD
    JOURNAL OF THE OPERATIONAL RESEARCH SOCIETY, 2001, 52 (05) : 503 - 510
  • [10] A "Method of Use " to Prevent Generic and Biosimilar Market Entry
    Tu, S. Sean
    Sarpatwari, Ameet
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (06): : 483 - 485